Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-26-081390
Filing Date
2026-07-24
Accepted
2026-07-24 16:16:57
Documents
17
Period of Report
2026-09-09

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT ea0298814-01.htm   iXBRL DEF 14A 920949
2 GRAPHIC tos_logo.jpg GRAPHIC 84536
3 GRAPHIC tos_logo1.jpg GRAPHIC 84547
4 GRAPHIC tproxy_001.jpg GRAPHIC 1176788
5 GRAPHIC tproxy_002.jpg GRAPHIC 1328253
  Complete submission text file 0001213900-26-081390.txt   7669846

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ostx-20251231.xsd EX-101.SCH 1436
7 XBRL LABEL FILE ostx-20251231_lab.xml EX-101.LAB 439
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0298814-01_htm.xml XML 5844
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

EIN.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-42195 | Film No.: 261201696
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)